United States: Supreme Court Rules Phoebe Putney’s Acquisition Is Not Immune Under The State-Action Doctrine

Last Updated: February 28 2013
Article by Charles F. (Rick) Rule, Andrew Forman, Brian T. McGovern, Nandu V. Machiraju and Dean B. Shaffer

Most Read Contributor in United States, October 2018

On February 19, 2013, the U.S. Supreme Court unanimously reversed the U.S. Court of Appeals for the Eleventh Circuit's decision in FTC v. Phoebe Putney Health System.1 The Eleventh Circuit had affirmed a district court ruling that Phoebe Putney Health System's acquisition of Palmyra Medical Center was immune from FTC antitrust scrutiny under Georgia law. In a decision penned by Justice Sonia Sotomayor, the Court, in its first application of the state-action doctrine to Section 7 of the Clayton Act, held that Georgia had not "clearly articulated and affirmatively expressed" a state policy of displacing the federal antitrust laws that would otherwise apply to Phoebe Putney's planned acquisition of Palmyra Hospital. As a result, the Supreme Court held that "state-action immunity" did not apply.2

Background

In 1941, Georgia enacted statutes to enable the State to take a more active role in Georgia's market for health care services, including allowing state and local authorities to create "hospital authorities." Hospital authorities are generally 5- to 9-member boards that are appointed by the governing body of the county or municipality and are empowered to exercise certain broad governmental functions.3

Also in 1941, the city of Albany and Dougherty County formed the Hospital Authority of Albany- Dougherty County, which then acquired Phoebe Putney Memorial Hospital. In 1971, Palmyra Medical Center (now operated by HCA, Inc.) was started in Dougherty County. In the six counties surrounding Albany, Phoebe Putney and Palmyra accounted for 86 percent of the market for acutecare hospital services provided to commercial hospital plans.4

In 2010, the Hospital Authority approved Phoebe Putney's acquisition of Palmyra.5 After reviewing the acquisition, the FTC issued an administrative complaint alleging that Phoebe Putney's purchase of Palmyra would substantially lessen competition.6 The FTC and the State of Georgia sued the Hospital Authority, Phoebe Putney, and Palmyra in district court to enjoin the transaction pending resolution of the administrative hearing.7 The U.S. District Court for the Middle District of Georgia denied the FTC's request for a preliminary injunction on the grounds that the acquisition was immune from antitrust liability under the state-action doctrine.8 On appeal, the Eleventh Circuit upheld the district court's decision.9

Supreme Court's Decision and Analysis

Under Parker v. Brown, state action that is anticompetitive is immune from Sherman Act attack.10 In other words, the Sherman Act is not intended to override legitimate actions of states even when those actions disturb private competition. So for example, the Supreme Court has found state regulation that directly, or indirectly through a subordinate body, restricts competition through zoning ordinances, limitations on the geographic reach of city services, or encouragement of collective ratemaking by common carriers is immune to Sherman Act attack where the state "clear[ly] articulat[es]" its intent to displace competition.11

In this case, the Supreme Court seemed to narrow or tighten the circumstances under which state subdivisions could claim the state action immunity.12 The Supreme Court ruled that Georgia hospital authorities were not eligible for immunity from FTC antitrust scrutiny under the state-action doctrine, because the Georgia law permitting the creation of hospital authorities did not "clearly articulate[] and affirmatively express[]" a state policy displacing the federal antitrust laws.13 The Court rejected the Eleventh Circuit's reasoning that the Georgia Legislature "'must have anticipated' that acquisitions by hospital authorities 'would produce anticompetitive effects.'"14 The "clear articulation" test, though it does not require an explicit statement, can only be fulfilled where the displacement of competition was the "inherent, logical, or ordinary result of the exercise of authority delegated by the state legislature."15 The Georgia law did not meet this test, as the statute "[was] not principally concerned with hospital authorities' ability to acquire multiple hospitals and consolidate their operations."16

The Court justified its narrower approach to the clear-articulation test by explaining that, under this approach, "national policies embodied in the antitrust laws" would not be "displaced by state delegations of authority intended to achieve more limited ends."17 Further, "loose application of the clear-articulation test would attach significant unintended consequences to States' frequent delegations of corporate authority to local bodies" by reading antitrust exemptions into state delegations of authority where no such exemption was intended.18

The Supreme Court, "declin[ing] to set such a trap for unwary state legislatures" and finding that the Georgia law did not clearly articulate a policy of displacement of the federal antitrust laws, reversed the Court of Appeals' ruling, held that the Phoebe Putney acquisition of Palmyra Hospital was not immune from FTC antitrust scrutiny under the state-action doctrine, and remanded the case for further proceedings.19

Implications

The Supreme Court's ruling may affect antitrust jurisprudence in the following ways.

  • The decision will probably tighten the state-action immunity.
  • It will likely reduce the ability of sub-state entities such as municipalities, cities, and counties to protect hospital and health system mergers approved by those entities from antitrust scrutiny.
  • Finally, although the decision narrowly spoke to issues implicated in the Phoebe Putney- Palmyra transaction, the decision – with its affirmation of the national goal of promoting competition – could have implications for Accountable Care Organizations and other entities created in furtherance of the Affordable Care Act.

Conclusion

Although the Supreme Court's decision pertains to the discrete subject of the state-action doctrine and may not have broad applicability across all aspects of antitrust law, it nevertheless represents a notable win for the FTC in a longstanding battle. Consequently, it continues the FTC's string of success in an area (hospital mergers) of particular focus in recent years.

Footnotes

1 663 F.3d 1369 (11th Cir. 2011), overruled by FTC v. Phoebe Putney Health System, 568 U.S. __ (2013).

2 FTC v. Phoebe Putney Health System, 568 U.S. __, at *1 (2013).

3 Id. at 2.

4 Id. at 3.

5 Id.

6 Press Release, Fed. Trade Comm'n, FTC and Georgia Attorney General Challenge Phoebe Putney Health System's Proposed Acquisition of Palmyra Park Hospital as Anticompetitive (Apr. 20, 2011), available at http://www.ftc.gov/opa/2011/04/phoebeputney.shtm.

7 Mot. for Prelim. Inj., FTC v. Phoebe Putney Health System, Inc., No. 1-11-cv-58 (M.D. Ga., Apr. 20, 2011).

8 FTC v. Phoebe Putney Health System, Inc., 792 F. Supp. 2d 1356 (M.D. Ga 2011).

9 FTC v. Phoebe Putney Health System, Inc., 663 F.3d 1369 (11th Cir. 2011).

10 317 U.S. 341, 352 (1943).

11 FTC v. Phoebe Putney Health System, 568 U.S. __, at *8-12 (2013); accord Columbia v. Omni Outdoor Advertising, Inc., 499 U.S. 365, 373 (1991); Hallie v. Eau Claire, 471 U.S. 34, 46-47 (1985); Southern Motor Carriers Rate Conference, Inc. v. United States, 471 U.S. 48, 64, 65, and n. 25 (1985).

12 Id. at *7 (quoting FTC v. Ticor Title Ins. Co., 504 U.S. 621, 636 (1992), for proposition that "state-action immunity is disfavored, much as are repeals by implication").

13 Id. at *19.

4 Id. at *11.

15 Id.

16 Id. at *14.

17 Id.

18 Id. at *18.

19 Id. at *18-19.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
Reinhart Boerner Van Deuren s.c.
Kilpatrick Townsend & Stockton LLP
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Reinhart Boerner Van Deuren s.c.
Kilpatrick Townsend & Stockton LLP
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions